ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 94

Smoking and The Risk For Incident Gouty Arthritis

Weiqi Wang1, Vidula Bhole2 and Eswar Krishnan3, 1medicine, stanford university, palo alto, CA, 2EpiSolutions Consultancy Services, Thane, India, 3Medicine, Stanford University, Palo Alto, CA

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Gout and tobacco use

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Historically, the published literature have suggested that smoking tobacco is associated with lower serum urate concentrations. However, whether smoking impacts the risk for incident gout or not has not been addressed in detail. Our aim was to test this hypothesis and assess if any such link is merely a reflection of the inverse relationship between smoking and obesity.

Methods:

The analysis was based on Framingham heart study (FHS) visits 1 to 26, covering 52 years from 1948 to 2000. Gout was defined by presence of any of the following:  self-report, physician diagnosis, gout medication use, and radiographic changes. Smoking was defined as any usage of tobacco. Hypertension was defined by presence of any of the following: systolic blood pressure >= 140 mm Hg or diastolic blood pressure >= 90 mm Hg or usage of anti-hypertensive medications. Diabetes were defined according to FHS official review. BMI was obtained from FHS raw data. Statistical analyses were performed using Cox proportional hazard regression models in STATA, where the dependent variable was the time from a patient first enrolled to his incident gout. All covariates that entered the multivariable models (smoking, sex, age, BMI, hypertension, diabetes, kidney disease and alcohol use) were treated as time varying in the regression models. Missing values were addressed by multiple imputations.

Results:

There were 5079 participants that were included, among whom 3703 used tobacco. At the baseline the proportion of men was 45.17%. Overall there were 414 incident cases of gout during the follow up. The incidence rate per thousand person-years of gout in the smoking group was 2.55 and in the non-smoking group was 4.57. The unadjusted and age adjusted hazard ratio of smoking were 0.75 (95% confidence interval 0.58-0.99) and 0.73 (0.55-0.96) respectively. In multivariable Cox models, smoking was associated with a hazard ratio of 0.65 (0.44-0.96). The results were not different when men and women were analyzed differently.

Conclusion: Smoking was associated with lower risk for gout and this association was not confounded by obesity or other risk factors.


Disclosure:

W. Wang,
None;

V. Bhole,
None;

E. Krishnan,

Takeda,

2,

takeda,

5.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/smoking-and-the-risk-for-incident-gouty-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology